Changes in the structures or functions in TAP lead to disruptions in APM by MHC and create an impact on the immune escape and downregulation of the MHC complex, leading to the heightened possibility of tumor cell invasion and subsequently leading to a reduced prognosis for CD8-targeted cancer treatment [15]. This evidence concerns the gene CD8A and cancer.